PubMed

Proteomics of Apolipoproteins and Associated Proteins From Plasma High-Density Lipoproteins.

Davidsson P, Hulthe J, Fagerberg B, Camejo G.

Arterioscler Thromb Vasc Biol. 2009 Sep 24. [Epub ahead of print]PMID: 19778948 [PubMed - as supplied by publisher]Related articles

Hypoxic regulation of secreted proteoglycans in macrophages.

Asplund A, Stillemark-Billton P, Larsson E, Rydberg EK, Moses J, Hultén LM, Fagerberg B, Camejo G, Bondjers G.

Glycobiology. 2010 Jan;20(1):33-40. Epub 2009 Sep 11.PMID: 19748976 [PubMed - as supplied by publisher]Related articles

Hypoxia increases macrophage motility, possibly by decreasing the heparan sulfate proteoglycan biosynthesis.

Asplund A, Ostergren-Lundén G, Camejo G, Stillemark-Billton P, Bondjers G.

J Leukoc Biol. 2009 Aug;86(2):381-8. Epub 2009 Apr 28.PMID: 19401393 [PubMed - indexed for MEDLINE]Related articles

The dual PPARalpha/gamma agonist tesaglitazar blocks progression of pre-existing atherosclerosis in APOE*3Leiden.CETP transgenic mice.

van der Hoorn JW, Jukema JW, Havekes LM, Lundholm E, Camejo G, Rensen PC, Princen HM.

Br J Pharmacol. 2009 Apr;156(7):1067-75. Epub 2009 Feb 13.PMID: 19220285 [PubMed - indexed for MEDLINE]Related articles

In vivo effects of myocardial creatine depletion on left ventricular function morphology and lipid metabolism: study in a mouse model.

Lindbom M, Ramunddal T, Camejo G, Waagstein F, Omerovic E.

J Card Fail. 2008 Mar;14(2):161-6.PMID: 18325464 [PubMed - indexed for MEDLINE]Related articles

Proteomics and lipids of lipoproteins isolated at low salt concentrations in D2O/sucrose or in KBr.

Ståhlman M, Davidsson P, Kanmert I, Rosengren B, Borén J, Fagerberg B, Camejo G.

J Lipid Res. 2008 Feb;49(2):481-90. Epub 2007 Nov 18.PMID: 18025001 [PubMed - indexed for MEDLINE]Related articlesFree article

Fatty acid-induced atherogenic changes in extracellular matrix proteoglycans.

Rodriguéz-Lee M, Bondjers G, Camejo G.

Curr Opin Lipidol. 2007 Oct;18(5):546-53. Review.PMID: 17885426 [PubMed - indexed for MEDLINE]Related articles

Tesaglitazar, a PPARalpha/gamma agonist, induces interstitial mesenchymal cell DNA synthesis and fibrosarcomas in subcutaneous tissues in rats.

Hellmold H, Zhang H, Andersson U, Blomgren B, Holland T, Berg AL, Elebring M, Sjögren N, Bamberg K, Dahl B, Westerberg R, Dillner B, Tugwood J, Tugwood J, Roberts R, Lundholm E, Camejo G, Skånberg I, Evans J.

Toxicol Sci. 2007 Jul;98(1):63-74. Epub 2007 Apr 27.PMID: 17468185 [PubMed - indexed for MEDLINE]Related articlesFree article

Beyond lipids, pharmacological PPARalpha activation has important effects on amino acid metabolism as studied in the rat.

Sheikh K, Camejo G, Lanne B, Halvarsson T, Landergren MR, Oakes ND.

Am J Physiol Endocrinol Metab. 2007 Apr;292(4):E1157-65. Epub 2006 Dec 12.PMID: 17164430 [PubMed - indexed for MEDLINE]Related articlesFree article

Distinctiveness of secretory phospholipase A2 group IIA and V suggesting unique roles in atherosclerosis.

Rosengren B, Jönsson-Rylander AC, Peilot H, Camejo G, Hurt-Camejo E.

Biochim Biophys Acta. 2006 Nov;1761(11):1301-8. Epub 2006 Jul 8. Review.PMID: 17070102 [PubMed - indexed for MEDLINE]Related articles

Dual PPARalpha/gamma agonist tesaglitazar reduces atherosclerosis in insulin-resistant and hypercholesterolemic ApoE*3Leiden mice.

Zadelaar AS, Boesten LS, Jukema JW, van Vlijmen BJ, Kooistra T, Emeis JJ, Lundholm E, Camejo G, Havekes LM.

Arterioscler Thromb Vasc Biol. 2006 Nov;26(11):2560-6. Epub 2006 Aug 24.PMID: 16931788 [PubMed - indexed for MEDLINE]Related articlesFree article

Fatty acids cause alterations of human arterial smooth muscle cell proteoglycans that increase the affinity for low-density lipoprotein.

Rodríguez-Lee M, Ostergren-Lundén G, Wallin B, Moses J, Bondjers G, Camejo G.

Arterioscler Thromb Vasc Biol. 2006 Jan;26(1):130-5. Epub 2005 Oct 20.PMID: 16239593 [PubMed - indexed for MEDLINE]Related articlesFree article

Tesaglitazar, a dual PPAR{alpha}/{gamma} agonist, ameliorates glucose and lipid intolerance in obese Zucker rats.

Oakes ND, Thalén P, Hultstrand T, Jacinto S, Camejo G, Wallin B, Ljung B.

Am J Physiol Regul Integr Comp Physiol. 2005 Oct;289(4):R938-46.PMID: 16183630 [PubMed - indexed for MEDLINE]Related articles

Differential antiatherogenic effects of PPARalpha versus PPARgamma agonists: should we be surprised?

Camejo G.

Arterioscler Thromb Vasc Biol. 2005 Sep;25(9):1763-4. No abstract available. PMID: 16127025 [PubMed - indexed for MEDLINE]Related articlesFree article

A proteomic study of the apolipoproteins in LDL subclasses in patients with the metabolic syndrome and type 2 diabetes.

Davidsson P, Hulthe J, Fagerberg B, Olsson BM, Hallberg C, Dahllöf B, Camejo G.

J Lipid Res. 2005 Sep;46(9):1999-2006. Epub 2005 Jul 1.PMID: 15995172 [PubMed - indexed for MEDLINE]Related articlesFree article

Hydrolytic enzymes released from resident macrophages and located in the intima extracellular matrix as agents that modify retained apolipoprotein B lipoproteins.

Camejo G.

Arterioscler Thromb Vasc Biol. 2003 Aug 1;23(8):1312-3. No abstract available. PMID: 12909567 [PubMed - indexed for MEDLINE]Related articlesFree article

Fatty acids modulate the effect of darglitazone on macrophage CD36 expression.

Svensson L, Camejo G, Cabré A, Vallvé JC, Pedreño J, Norén K, Wiklund O, Hultén LM.

Eur J Clin Invest. 2003 Jun;33(6):464-71.PMID: 12795642 [PubMed - indexed for MEDLINE]Related articles

PPAR agonists in the treatment of insulin resistance and associated arterial disease.

Camejo G.

Int J Clin Pract Suppl. 2003 Mar;(134):36-44. Review.PMID: 12793596 [PubMed - indexed for MEDLINE]Related articles

Phospholipase A2 modification of lipoproteins: potential effects on atherogenesis.

Sartipy P, Camejo G, Svensson L, Hurt-Camejo E.

Adv Exp Med Biol. 2002;507:3-7. Review. No abstract available. PMID: 12664556 [PubMed - indexed for MEDLINE]Related articles

AZ 242, a novel PPARalpha/gamma agonist with beneficial effects on insulin resistance and carbohydrate and lipid metabolism in ob/ob mice and obese Zucker rats.

Ljung B, Bamberg K, Dahllöf B, Kjellstedt A, Oakes ND, Ostling J, Svensson L, Camejo G.

J Lipid Res. 2002 Nov;43(11):1855-63.PMID: 12401884 [PubMed - indexed for MEDLINE]Related articlesFree article

Correction of dysfunctional fatty acid metabolism using peroxisome proliferator activated receptor gamma agonists.

Oakes ND, Ljung B, Camejo G.

J R Soc Med. 2002;95 Suppl 42:33-8. Review. No abstract available. PMID: 12216325 [PubMed - indexed for MEDLINE]Related articlesFree article

The extracellular matrix on atherogenesis and diabetes-associated vascular disease.

Camejo G, Olsson U, Hurt-Camejo E, Baharamian N, Bondjers G.

Atheroscler Suppl. 2002 May;3(1):3-9. Review.PMID: 12044579 [PubMed - indexed for MEDLINE]Related articles

Pharmacological treatment of insulin resistance in obesity.

Camejo G, Ljung B, Oakes N.

Nutr Metab Cardiovasc Dis. 2001 Aug;11(4):275-84. Review.PMID: 11831112 [PubMed - indexed for MEDLINE]Related articles

Elevated levels of small, low-density lipoprotein with high affinity for arterial matrix components in patients with rheumatoid arthritis: possible contribution of phospholipase A2 to this atherogenic profile.

Hurt-Camejo E, Paredes S, Masana L, Camejo G, Sartipy P, Rosengren B, Pedreno J, Vallve JC, Benito P, Wiklund O.

Arthritis Rheum. 2001 Dec;44(12):2761-7.PMID: 11762936 [PubMed - indexed for MEDLINE]Related articles

Changes in matrix proteoglycans induced by insulin and fatty acids in hepatic cells may contribute to dyslipidemia of insulin resistance.

Olsson U, Egnell AC, Lee MR, Lundén GO, Lorentzon M, Salmivirta M, Bondjers G, Camejo G.

Diabetes. 2001 Sep;50(9):2126-32.PMID: 11522680 [PubMed - indexed for MEDLINE]Related articlesFree article

Phospholipase A(2) in vascular disease.

Hurt-Camejo E, Camejo G, Peilot H, Oörni K, Kovanen P.

Circ Res. 2001 Aug 17;89(4):298-304. Review.PMID: 11509445 [PubMed - indexed for MEDLINE]Related articlesFree article

Intravascular hemolysis increases atherogenicity of diet-induced hypercholesterolemia in rabbits in spite of heme oxygenase-1 gene and protein induction.

Fernandez AZ, López F, Tablante A, Romano E, Hurt-Camejo E, Camejo G, Apitz-Castro R.

Atherosclerosis. 2001 Sep;158(1):103-11.PMID: 11500180 [PubMed - indexed for MEDLINE]Related articles

[Why are plasmatic apoB lipoproteins atherogenic? The hypothesis of response to retention]

Hurt-Camejo E, Camejo G.

Invest Clin. 2001 May;42 Suppl 1:43-73. Review. Spanish. PMID: 11416984 [PubMed - indexed for MEDLINE]Related articles

Lipid mediators that modulate the extracellular matrix structure and function in vascular cells.

Camejo G, Hurt-Camejo E, Olsson U, Bondjers G.

Curr Atheroscler Rep. 1999 Sep;1(2):142-9. Review.PMID: 11122703 [PubMed - indexed for MEDLINE]Related articles

Phospholipase A2 and small, dense low-density lipoprotein.

Hurt-Camejo E, Camejo G, Sartipy P.

Curr Opin Lipidol. 2000 Oct;11(5):465-71. Review.PMID: 11048889 [PubMed - indexed for MEDLINE]Related articles

Phospholipase A(2) modification of low density lipoproteins forms small high density particles with increased affinity for proteoglycans and glycosaminoglycans.

Sartipy P, Camejo G, Svensson L, Hurt-Camejo E.

J Biol Chem. 1999 Sep 3;274(36):25913-20.PMID: 10464335 [PubMed - indexed for MEDLINE]Related articlesFree article

CD44, a cell surface chondroitin sulfate proteoglycan, mediates binding of interferon-gamma and some of its biological effects on human vascular smooth muscle cells.

Hurt-Camejo E, Rosengren B, Sartipy P, Elfsberg K, Camejo G, Svensson L.

J Biol Chem. 1999 Jul 2;274(27):18957-64.PMID: 10383394 [PubMed - indexed for MEDLINE]Related articlesFree article

Development and initial evaluation of a novel method for assessing tissue-specific plasma free fatty acid utilization in vivo using (R)-2-bromopalmitate tracer.

Oakes ND, Kjellstedt A, Forsberg GB, Clementz T, Camejo G, Furler SM, Kraegen EW, Olwegård-Halvarsson M, Jenkins AB, Ljung B.

J Lipid Res. 1999 Jun;40(6):1155-69.PMID: 10357848 [PubMed - indexed for MEDLINE]Related articlesFree article

Proteoglycans contribution to association of Lp(a) and LDL with smooth muscle cell extracellular matrix.

Lundstam U, Hurt-Camejo E, Olsson G, Sartipy P, Camejo G, Wiklund O.

Arterioscler Thromb Vasc Biol. 1999 May;19(5):1162-7.PMID: 10323765 [PubMed - indexed for MEDLINE]Related articlesFree article

Fatty acids modulate the composition of extracellular matrix in cultured human arterial smooth muscle cells by altering the expression of genes for proteoglycan core proteins.

Olsson U, Bondjers G, Camejo G.

Diabetes. 1999 Mar;48(3):616-22.PMID: 10078565 [PubMed - indexed for MEDLINE]Related articlesFree article

Analysis of oxidation and antioxidants using microtiter plates.

Camejo G, Wallin B, Enojärvi M.

Methods Mol Biol. 1998;108:377-87. No abstract available. PMID: 9921546 [PubMed - indexed for MEDLINE]Related articles

Measurements of proteoglycan-lipoprotein interaction by gel mobility shift assay.

Hurt-Camejo E, Camejo G, Sartipy P.

Methods Mol Biol. 1998;110:267-79. Review. No abstract available. PMID: 9918053 [PubMed - indexed for MEDLINE]Related articles

Association of apo B lipoproteins with arterial proteoglycans: pathological significance and molecular basis.

Camejo G, Hurt-Camejo E, Wiklund O, Bondjers G.

Atherosclerosis. 1998 Aug;139(2):205-22. Review.PMID: 9712326 [PubMed - indexed for MEDLINE]Related articles

Hemin binding and oxidation of lipoproteins in serum: mechanisms and effect on the interaction of LDL with human macrophages.

Camejo G, Halberg C, Manschik-Lundin A, Hurt-Camejo E, Rosengren B, Olsson H, Hansson GI, Forsberg GB, Ylhen B.

J Lipid Res. 1998 Apr;39(4):755-66.PMID: 9555941 [PubMed - indexed for MEDLINE]Related articlesFree article

Potential involvement of type II phospholipase A2 in atherosclerosis.

Hurt-Camejo E, Camejo G.

Atherosclerosis. 1997 Jul 11;132(1):1-8. Review. No abstract available. PMID: 9247353 [PubMed - indexed for MEDLINE]Related articles

Cellular consequences of the association of apoB lipoproteins with proteoglycans. Potential contribution to atherogenesis.

Hurt-Camejo E, Olsson U, Wiklund O, Bondjers G, Camejo G.

Arterioscler Thromb Vasc Biol. 1997 Jun;17(6):1011-7. Review.PMID: 9194748 [PubMed - indexed for MEDLINE]Related articlesFree article

Possible functional interactions of apolipoprotein B-100 segments that associate with cell proteoglycans and the ApoB/E receptor.

Olsson U, Camejo G, Hurt-Camejo E, Elfsber K, Wiklund O, Bondjers G.

Arterioscler Thromb Vasc Biol. 1997 Jan;17(1):149-55.PMID: 9012650 [PubMed - indexed for MEDLINE]Related articlesFree article

Multifactorial treatment of hypertensive men at high cardiovascular risk and low-density lipoprotein cholesterol affinity to human arterial proteoglycans.

Fagerberg B, Wiklund O, Agewall S, Camejo G, Wikstrand RJ.

Eur J Clin Invest. 1996 Nov;26(11):960-5.PMID: 8957200 [PubMed - indexed for MEDLINE]Related articles

Binding of human phospholipase A2 type II to proteoglycans. Differential effect of glycosaminoglycans on enzyme activity.

Sartipy P, Johansen B, Camejo G, Rosengren B, Bondjers G, Hurt-Camejo E.

J Biol Chem. 1996 Oct 18;271(42):26307-14.PMID: 8824283 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of olive and sunflower oils on low density lipoprotein level, composition, size, oxidation and interaction with arterial proteoglycans.

Carmena R, Ascaso JF, Camejo G, Varela G, Hurt-Camejo E, Ordovas JM, Martinez-Valls J, Bergstöm M, Wallin B.

Atherosclerosis. 1996 Sep 6;125(2):243-55.PMID: 8842355 [PubMed - indexed for MEDLINE]Related articles

Insoluble complex formation between LDL and arterial proteoglycans in relation to serum lipid levels and effects of lipid lowering drugs.

Wiklund O, Bondjers G, Wright I, Camejo G.

Atherosclerosis. 1996 Jan 5;119(1):57-67.PMID: 8929256 [PubMed - indexed for MEDLINE]Related articles

Interferon gamma binds to extracellular matrix chondroitin-sulfate proteoglycans, thus enhancing its cellular response.

Camejo EH, Rosengren B, Camejo G, Sartipy P, Fager G, Bondjers G.

Arterioscler Thromb Vasc Biol. 1995 Sep;15(9):1456-65.PMID: 7670961 [PubMed - indexed for MEDLINE]Related articlesFree article

Binding of platelet-derived growth factor and low density lipoproteins to glycosaminoglycan species produced by human arterial smooth muscle cells.

Fager G, Camejo G, Olsson U, Ostergren-Lundén G, Lustig F, Bondjers G.

J Cell Physiol. 1995 May;163(2):380-92.PMID: 7706380 [PubMed - indexed for MEDLINE]Related articles

Lipoprotein oxidation and measurement of hydroperoxide formation in a single microtitre plate.

Wallin B, Camejo G.

Scand J Clin Lab Invest. 1994 Jul;54(4):341-6.PMID: 7939379 [PubMed - indexed for MEDLINE]Related articles

Lipoprotein fractionation in deuterium oxide gradients: a procedure for evaluation of antioxidant binding and susceptibility to oxidation.

Hallberg C, Hådén M, Bergström M, Hanson G, Pettersson K, Westerlund C, Bondjers G, Ostlund-Lindqvist AM, Camejo G.

J Lipid Res. 1994 Jan;35(1):1-9.PMID: 8138709 [PubMed - indexed for MEDLINE]Related articlesFree article